Cite
HARVARD Citation
Ichimiya, S. et al. (2022). Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma. Immunological investigations. pp. 1498-1514. [Online].